Health insurance as a moderator in the relationship between financial toxicity and medical cost‐coping behaviors: Evidence from patients with lung cancer in China

Documenti analoghi

• Understanding the financial cost of cancer clinical trial participation
  di: Courtney P. Williams, et al.
  Pubblicazione: (2024)
• Real‐world analysis of the relationships between smoking, lung cancer stigma, and emotional functioning
  di: Kari Chansky, et al.
  Pubblicazione: (2024)
• What is the relationship between the local population change and cancer incidence in patients with dyslipidemia: Evidence of the impact of local extinction in Korea
  di: Wonjeong Jeong, et al.
  Pubblicazione: (2024)
• Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer
  di: Yuxuan Hao, et al.
  Pubblicazione: (2024)
• Combination tumor‐treating fields treatment for patients with metastatic non‐small cell lung cancer: A cost‐effectiveness analysis
  di: Kun Liu, et al.
  Pubblicazione: (2024)